4-(pyrrolidin-1-ylmethyl)benzonitrile | 78064-96-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(pyrrolidin-1-ylmethyl)benzonitrile
• 英文别名: N-(4-cyanophenylmethyl)pyrrolidine；1-(4-cyanophenyl)pyrrolidine；N-(p-cyanobenzyl)pyrrolidine；4-(1-pyrrolidin-1-ylmethyl)-benzonitrile；4-(pyrrolidin-1-ylmethyl)-benzonitrile
• CAS: 78064-96-7
• 化学式: C₁₂H₁₄N₂
• mdl: MFCD07325398
• 分子量: 186.257
• InChiKey: CURIZTVQZBYWBR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.416
• 拓扑面积：
  27
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2933990090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-(Pyrrolidin-1-ylmethyl)benzonitrile
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-(Pyrrolidin-1-ylmethyl)benzonitrile
CAS number: 78064-96-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C12H14N2
Molecular weight: 186.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-(pyrrolidin-1-ylmethyl)benzonitrile 在 sodium tetrahydroborate 、 nickel(II) chloride hexahydrate 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三乙胺 作用下， 以 乙醇 、 二氯甲烷 为溶剂， 反应 25.0h， 生成 N-(4-(pyrrolidin-1-ylmethyl)benzyl)-2-amino-4-nitrobenzamide
  参考文献：
  名称：

  Mimicking the Intramolecular Hydrogen Bond: Synthesis, Biological Evaluation, and Molecular Modeling of Benzoxazines and Quinazolines as Potential Antimalarial Agents

  摘要：

  The intramolecular hydrogen bond formed between a protonated amine and a neighboring H-bond acceptor group in the side chain of amodiaquine and isoquine is thought to play an important role in their antimalarial activities. Here we describe isoquine-based compounds in which the intramolecular H-bond is mimicked by a methylene linker. The antimalarial activities of the resulting benzoxazines, their isosteric tetrahydroquinazoline derivatives, and febrifugine-based 1,3-quinazolin-4-ones were examined in vitro (against Plasmodium falciparum) and in vivo (against Plasmodium berghei). Compounds 6b,c caused modest inhibition of chloroquine transport via the parasite's "chloroquine resistance transporter" (PfCRT) in a Xenopus laevis oocyte expression system. In silico predictions and experimental evaluation of selected drug-like properties were also performed on compounds 6b,c. Compound 6c emerged from this work as the most promising analogue of the series; it possessed low toxicity and good antimalarial activity when administered orally to P. berghei-infected mice.

  DOI：

  10.1021/jm300831b
• 作为产物：
  描述：

  4-溴苯腈 在 tris(2,2-bipyridine)ruthenium(II) hexafluorophosphate 、 Eosin Y 、 C₁₂H₁₆N₂NiO₄⁽²⁺⁾*2Cl^(1-) 作用下， 以 甲醇 、 二甲基亚砜 、 乙腈 为溶剂， 反应 3.0h， 生成 4-(pyrrolidin-1-ylmethyl)benzonitrile
  参考文献：
  名称：

  曙红Y促进芳香砜的无金属氨基甲基化

  摘要：

  报道了杂环与有机染料的光催化氨甲基化。通过氨基甲基自由基形成的 C-C 键可以一步获得一系列功能化的杂环，而无需过渡金属。

  DOI：

  10.1002/chem.202102124

文献信息

• Hydrogen-free reductive amination using iron pentacarbonyl as a reducing agent
  作者：Oleg I. Afanasyev、Dmitry L. Usanov、Denis Chusov

  DOI：10.1039/c7ob02795h

  日期：——

  We developed solvent-free reductive amination without an external hydrogen source using iron pentacarbonyl as a reducing agent. Neither a catalyst nor any other additives were employed. Various types of substrates are suitable for the reaction, including those with low reactivity, e.g. benzophenone. Among others, the protocol tolerates bromo-, cyano-, benzyloxy-, pyrimidyl and styryl moieties.

  我们使用五羰基铁作为还原剂，开发了无溶剂的无需外部氢源的还原胺化方法。既未使用催化剂也未使用任何其他添加剂。各种类型的底物都适合该反应，包括低反应性的底物，例如二苯甲酮。其中，该方案耐受溴，氰基，苄氧基，嘧啶基和苯乙烯基部分。
• Development of Inhibitors against <i>Mycobacterium abscessus</i> tRNA (m¹G37) Methyltransferase (TrmD) Using Fragment-Based Approaches
  作者：Andrew J. Whitehouse、Sherine E. Thomas、Karen P. Brown、Alexander Fanourakis、Daniel S.-H. Chan、M. Daben J. Libardo、Vitor Mendes、Helena I. M. Boshoff、R. Andres Floto、Chris Abell、Tom L. Blundell、Anthony G. Coyne

  DOI：10.1021/acs.jmedchem.9b00809

  日期：2019.8.8

  with improved efficacy. tRNA (m1G37) methyltransferase (TrmD) is a promising target for novel antibiotics. It is essential in Mab and other mycobacteria, improving reading frame maintenance on the ribosome to prevent frameshift errors. In this work, a fragment-based approach was employed with the merging of two fragments bound to the active site, followed by structure-guided elaboration to design potent

  脓肿分枝杆菌 (Mab) 是一种快速增长的多重耐药非结核分枝杆菌，对囊性纤维化和其他已有慢性肺部疾病的患者构成越来越大的威胁。单克隆抗体肺部感染很难治疗，有时甚至不可能治疗，会导致肺功能加速衰退和过早死亡。因此，迫切需要开发具有改善功效的新型抗生素。tRNA (m1G37) 甲基转移酶 (TrmD) 是新型抗生素的一个有前景的靶标。它对于 Mab 和其他分枝杆菌至关重要，可改善核糖体上的读码框维护以防止移码错误。在这项工作中，采用基于片段的方法，合并与活性位点结合的两个片段，然后进行结构引导的精加工，以设计针对 Mab TrmD 的有效纳摩尔抑制剂。其中几种化合物对分枝杆菌物种表现出有希望的活性，除了 Mab 之外，还包括结核分枝杆菌和麻风分枝杆菌，支持使用 TrmD 作为开发抗分枝杆菌化合物的靶点。
• [EN] PYRAZOLOPYRIMIDINES AS KINASE INHIBITORS<br/>[FR] INHIBITEURS DE KINASE SOUS FORME DE PYRAZOLOPYRIMIDINES
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2004009602A1

  公开（公告）日：2004-01-29

  The present invention relates generally to inhibitors of the kinases and more particularly to novel pyrazolopyrimidine compounds.

  本发明一般涉及激酶的抑制剂，更具体地涉及新型吡唑吡嘧啶化合物。
• Regioselective Synthesis of Acylated <i>N</i>-Heterocycles via the Cascade Reactions of Saturated Cyclic Amines with 2-Oxo-2-arylacetic Acids
  作者：Xiaonan Shi、Xi Chen、Muhua Wang、Xinying Zhang、Xuesen Fan

  DOI：10.1021/acs.joc.8b00805

  日期：2018.6.15

  in this cascade process, the copper catalyst is believed to play a crucial role not only in dehydrogenation but also in the decarboxylation and cross coupling reaction. To the best of our knowledge, this is the first example in which different classes of acylated N-heterocycles were directly prepared from the readily available saturated cyclic amines by using 2-oxo-2-arylacetic acids as the noncorrosive

  提出了由饱和环胺与2-氧代-2-芳基酸的级联反应的高度区域选择性和通用性的酰化的N-杂环的合成。从机理上讲，标题化合物的形成首先涉及环胺的C（sp 3）-H键脱氢生成烯胺中间体，然后使其与通过2-oxo-2-的脱羧反应而产生的酰基物质发生交叉偶联。芳酸。有趣的是，在该级联过程中，据信铜催化剂不仅在脱氢中而且在脱羧和交叉偶联反应中都起着至关重要的作用。据我们所知，这是第一个例子，其中不同种类的酰化N通过使用2-氧代-2-芳基乙酸作为非腐蚀性和易于处理的酰化试剂，由易于获得的饱和环胺直接制得-杂环。与文献方法相比，该新方案具有容易获得的底物，广泛的底物范围，高效率和良好的选择性等优点。
• 一种3-酰基吡咯类化合物的合成方法
  申请人：河南师范大学

  公开号：CN108503572B

  公开（公告）日：2021-02-02

  本发明公开了一种3‑酰基吡咯类化合物的合成方法，属于有机合成技术领域。以饱和五元环胺和2‑氧代‑2‑芳基乙酸为原料，通过一锅串联反应直接得到3‑酰基吡咯类化合物，具体操作为：将饱和五元环胺类化合物1和2‑氧代‑2‑芳基乙酸2溶于有机溶剂中，然后加入铜盐催化剂和氧化剂，加热至50‑80℃反应后得到3‑酰基二氢吡咯类化合物3或3‑酰基吡咯类化合物4。本发明对于化合物1中氮原子上R1为烷基或芳基类取代时，经过同样的反应条件得到不同类型的产物，整个过程操作方便，条件温和，底物适用范围广，具有潜在的工业化应用前景。